Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2011

01-12-2011 | Commentary

Clinical pharmacists and basic scientists: do patients and physicians need this collaboration?

Authors: Amir H. Zargarzadeh, Susan Jacob, Roger S. Klotz, Fadi T. Khasawneh

Published in: International Journal of Clinical Pharmacy | Issue 6/2011

Login to get access

Abstract

The aim of this commentary is to highlight the vital and beneficial role that pharmacists and inter-professional collaborative practice play in patient care from the economic, humanistic, efficacy, and safety perspectives. Pharmacists, particularly those with an in-depth knowledge of the basic pharmaceutical sciences, recognize the need to collaborate with other healthcare professions and understand the importance of combining all of the components of their education into a well-rounded, comprehensive clinical practice. Indeed, there is ample evidence in the literature that pharmacists equipped with a solid foundation in basic pharmaceutical science, coupled with clinical knowledge and skills can, more effectively, contribute to pharmacotherapy and patient care, particularly in a collaborative practice setting. Consequently, the burden on pharmacy education is to maintain its emphasis on the basic sciences while promoting the application of these sciences in clinical practice, in the Pharm. D. curriculum. This is a goal that can also be achieved through inter-professional educational approaches.
Literature
2.
3.
go back to reference Truffer CJ, Keehan S, Smith S, Cylus J, et al. Health spending projections through 2019: the recession’s impact continues. Health Aff. 2010;29:522–9.CrossRef Truffer CJ, Keehan S, Smith S, Cylus J, et al. Health spending projections through 2019: the recession’s impact continues. Health Aff. 2010;29:522–9.CrossRef
4.
go back to reference World Health Organization 2000 Report. Health systems: improving performance. Geneva: World Health Organization. ISBN 92 4 156198 X. World Health Organization 2000 Report. Health systems: improving performance. Geneva: World Health Organization. ISBN 92 4 156198 X.
7.
go back to reference Anaya JP, Rivera JO, Lawson K, Garcia J, et al. Evaluation of pharmacist managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm. 2008;65:1841–5.PubMedCrossRef Anaya JP, Rivera JO, Lawson K, Garcia J, et al. Evaluation of pharmacist managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm. 2008;65:1841–5.PubMedCrossRef
8.
go back to reference Bjornson DC, Hiner WO Jr, Potyk RP, Nelson BA, et al. Effect of pharmacist on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50:1875–84.PubMed Bjornson DC, Hiner WO Jr, Potyk RP, Nelson BA, et al. Effect of pharmacist on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50:1875–84.PubMed
9.
go back to reference Bond CA, Raehl Cl. Clinical and economic outcomes of pharmacist managed antimicrobial prophylaxis in surgical patients. Am J Health Syst Pharm. 2007;64:1935–42.PubMedCrossRef Bond CA, Raehl Cl. Clinical and economic outcomes of pharmacist managed antimicrobial prophylaxis in surgical patients. Am J Health Syst Pharm. 2007;64:1935–42.PubMedCrossRef
10.
go back to reference Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, et al. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997;45:1591–5. Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, et al. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997;45:1591–5.
11.
go back to reference Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203–11. 3p following 211.CrossRef Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203–11. 3p following 211.CrossRef
12.
go back to reference Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955–64.PubMedCrossRef Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166:955–64.PubMedCrossRef
13.
go back to reference Ponniah A, Anderson B, Shabkib S, Doecke CJ, et al. Pharmacists’ role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther. 2007;32:343–52.PubMedCrossRef Ponniah A, Anderson B, Shabkib S, Doecke CJ, et al. Pharmacists’ role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther. 2007;32:343–52.PubMedCrossRef
15.
go back to reference Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691–8.PubMed Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med. 2003;29:691–8.PubMed
16.
go back to reference Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother. 1999;33:1336–55.PubMedCrossRef Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother. 1999;33:1336–55.PubMedCrossRef
17.
go back to reference Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs and patient outcomes. Cochrane Database Syst. 2000; CD000336. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs and patient outcomes. Cochrane Database Syst. 2000; CD000336.
18.
go back to reference Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144–53.PubMedCrossRef Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25:144–53.PubMedCrossRef
19.
go back to reference Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421–36.PubMedCrossRef Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421–36.PubMedCrossRef
20.
go back to reference Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta analysis in diabetes management. Ann Pharmacother. 2007;41:1569–82.PubMedCrossRef Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta analysis in diabetes management. Ann Pharmacother. 2007;41:1569–82.PubMedCrossRef
21.
go back to reference Morrison A, Wertheimer AI. Evaluation of studies investigating the effectiveness of pharmacists’ clinical services. Am J Health Syst Pharm. 2001;58:569–77.PubMed Morrison A, Wertheimer AI. Evaluation of studies investigating the effectiveness of pharmacists’ clinical services. Am J Health Syst Pharm. 2001;58:569–77.PubMed
22.
go back to reference Holland R, Desborough J, Goodyer L, Hall S, et al. Does pharmacist-led medication review help to reduce hospital admissions and death in older people? A systematic review and meta analysis. Br J Clin Pharmacol. 2008;65:303–16.PubMedCrossRef Holland R, Desborough J, Goodyer L, Hall S, et al. Does pharmacist-led medication review help to reduce hospital admissions and death in older people? A systematic review and meta analysis. Br J Clin Pharmacol. 2008;65:303–16.PubMedCrossRef
23.
go back to reference Pickard AS, Hung SY. An update on evidence of clinical pharmacy services’ impact on health-related quality of life. Ann Pharmacother. 2006;40:1623–34.PubMedCrossRef Pickard AS, Hung SY. An update on evidence of clinical pharmacy services’ impact on health-related quality of life. Ann Pharmacother. 2006;40:1623–34.PubMedCrossRef
24.
go back to reference Machado M, Nassor N, Bajcar JM, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta analysis in hyperlipidemia management. Ann Pharmacother. 2008;42:1195–207.PubMedCrossRef Machado M, Nassor N, Bajcar JM, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta analysis in hyperlipidemia management. Ann Pharmacother. 2008;42:1195–207.PubMedCrossRef
25.
go back to reference Doucette WR, Witrlky MJ, Farrisk KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009;43:882–9.PubMedCrossRef Doucette WR, Witrlky MJ, Farrisk KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009;43:882–9.PubMedCrossRef
26.
go back to reference McFarland MS, Cross LB, Gross B, Gentry C, et al. Drug use evaluation of Sitagliptin dosing by pharmacist versus non-pharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic. J Manag Care Pharm. 2009;15:563–7.PubMed McFarland MS, Cross LB, Gross B, Gentry C, et al. Drug use evaluation of Sitagliptin dosing by pharmacist versus non-pharmacist clinicians in an internal medicine department of a private physician-owned multispecialty clinic. J Manag Care Pharm. 2009;15:563–7.PubMed
27.
go back to reference Taddei S, Bruno RM, Ghiadoni L. The correct administration of antihypertensive drugs according to the principles of clinical pharmacology. Am J Cardiovasc Drugs. 2011;11:13–20.PubMedCrossRef Taddei S, Bruno RM, Ghiadoni L. The correct administration of antihypertensive drugs according to the principles of clinical pharmacology. Am J Cardiovasc Drugs. 2011;11:13–20.PubMedCrossRef
28.
go back to reference Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta analysis in hypertension management. Ann Pharmacother. 2007;41:1770–81.PubMedCrossRef Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta analysis in hypertension management. Ann Pharmacother. 2007;41:1770–81.PubMedCrossRef
29.
go back to reference Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421–6.PubMedCrossRef Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421–6.PubMedCrossRef
30.
go back to reference Iyer R, Coderre P, McKelvey T, Cooper J, et al. An employer-based, pharmacist intervention model for patients with type 2 diabetes. Am J Health Syst Pharm. 2010;67:312–6.PubMedCrossRef Iyer R, Coderre P, McKelvey T, Cooper J, et al. An employer-based, pharmacist intervention model for patients with type 2 diabetes. Am J Health Syst Pharm. 2010;67:312–6.PubMedCrossRef
31.
go back to reference LaMarr B, Valdez C, Driscoll K, Ryan M. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients. Am J Health Syst Pharm. 2010;67:290–4.PubMedCrossRef LaMarr B, Valdez C, Driscoll K, Ryan M. Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients. Am J Health Syst Pharm. 2010;67:290–4.PubMedCrossRef
32.
go back to reference Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49:164–70.CrossRef Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49:164–70.CrossRef
33.
go back to reference Carter BL, Ardery G, Dawson JD, James PA, et al. Physician and Pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996–2002.PubMedCrossRef Carter BL, Ardery G, Dawson JD, James PA, et al. Physician and Pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996–2002.PubMedCrossRef
34.
go back to reference Weber CA, Ernst ME, Sezate GS, Zheng S, et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170:1634–9.PubMedCrossRef Weber CA, Ernst ME, Sezate GS, Zheng S, et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170:1634–9.PubMedCrossRef
35.
go back to reference Birtcher KK, Greisinger AJ, Brehm BJ, Wehmanen OA, et al. A secondary prevention lipid clinic reaches low-density lipoprotein cholesterol goals more often than usual cardiology care with coronary heart disease. J Clin Lipidol. 2010;4:46–52.PubMedCrossRef Birtcher KK, Greisinger AJ, Brehm BJ, Wehmanen OA, et al. A secondary prevention lipid clinic reaches low-density lipoprotein cholesterol goals more often than usual cardiology care with coronary heart disease. J Clin Lipidol. 2010;4:46–52.PubMedCrossRef
36.
go back to reference Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy. 2010;30:330–8.PubMedCrossRef Rudd KM, Dier JG. Comparison of two different models of anticoagulation management services with usual medical care. Pharmacotherapy. 2010;30:330–8.PubMedCrossRef
37.
go back to reference Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, et al. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2011;34:20–6.PubMedCrossRef Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, et al. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2011;34:20–6.PubMedCrossRef
38.
go back to reference Bunting BA, Smith BH, Sutherland SE. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173–84.CrossRef Bunting BA, Smith BH, Sutherland SE. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173–84.CrossRef
39.
go back to reference Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff. 2010;29:906–13.CrossRef Smith M, Bates DW, Bodenheimer T, Cleary PD. Why pharmacists belong in the medical home. Health Aff. 2010;29:906–13.CrossRef
40.
go back to reference Ting HJ, Khasawneh FT. Glybenclamide: an antidiabetic with in vivo antithrombotic activity. Eur J Pharmacol. 2010;649:249–54.PubMedCrossRef Ting HJ, Khasawneh FT. Glybenclamide: an antidiabetic with in vivo antithrombotic activity. Eur J Pharmacol. 2010;649:249–54.PubMedCrossRef
41.
go back to reference Nunez A, Gomez J, Zalba LR, Monton M, et al. Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan. J Renin Angiotensin Aldosterone Syst. 2000;1:175–9.PubMedCrossRef Nunez A, Gomez J, Zalba LR, Monton M, et al. Losartan inhibits in vitro platelet activation: comparison with candesartan and valsartan. J Renin Angiotensin Aldosterone Syst. 2000;1:175–9.PubMedCrossRef
42.
go back to reference Basaria S, Coviello AD, Travison TG, Storer TW, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:109–22.PubMedCrossRef Basaria S, Coviello AD, Travison TG, Storer TW, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:109–22.PubMedCrossRef
43.
go back to reference Phillips GB. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:1866.PubMed Phillips GB. Adverse events associated with testosterone administration. N Engl J Med. 2010;363:1866.PubMed
44.
go back to reference Chatterjee R, Yeh H-C, Shafi T. Serum and dietary potassium and risk of incident type 2 diabetes mellitus. Arch Intern Med. 2010;170:1745–51.PubMedCrossRef Chatterjee R, Yeh H-C, Shafi T. Serum and dietary potassium and risk of incident type 2 diabetes mellitus. Arch Intern Med. 2010;170:1745–51.PubMedCrossRef
45.
go back to reference Sudano I, Flammer AJ, Périat D, Enseleit F, et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation. 2010;122:1789–96.PubMedCrossRef Sudano I, Flammer AJ, Périat D, Enseleit F, et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation. 2010;122:1789–96.PubMedCrossRef
48.
go back to reference Ryu KH, Han HY, Lee SY, Jeon SD, et al. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res. 2009;124:328–34.PubMedCrossRef Ryu KH, Han HY, Lee SY, Jeon SD, et al. Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res. 2009;124:328–34.PubMedCrossRef
49.
go back to reference Mohamed ME, Frye RF. Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. Planta Med; 2010 Nov 3 [ahead of print]. Mohamed ME, Frye RF. Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. Planta Med; 2010 Nov 3 [ahead of print].
50.
go back to reference Zhu H, Butera M, Nelson D, Liu C. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J. 2005;2:80.PubMedCrossRef Zhu H, Butera M, Nelson D, Liu C. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication. Virol J. 2005;2:80.PubMedCrossRef
51.
go back to reference Cavallari LH, Overholser BR, Anderson D, Boyce E, et al. Recommended basic science foundation necessary to prepare pharmacists to manage personalized pharmacotherapy. Pharmacotherapy. 2010;30:228e–35e.CrossRef Cavallari LH, Overholser BR, Anderson D, Boyce E, et al. Recommended basic science foundation necessary to prepare pharmacists to manage personalized pharmacotherapy. Pharmacotherapy. 2010;30:228e–35e.CrossRef
52.
go back to reference McNair PP. The case for educating health care students in professionalism as the core content of inter-professional education. Med Educ. 2005;39:456–64.PubMedCrossRef McNair PP. The case for educating health care students in professionalism as the core content of inter-professional education. Med Educ. 2005;39:456–64.PubMedCrossRef
53.
go back to reference Chisholm-Burns MA, Lee JK, Spivey CA, Slack M, et al. US pharmacists effect as team members on patient care. Med Care. 2010;48:923–33.PubMedCrossRef Chisholm-Burns MA, Lee JK, Spivey CA, Slack M, et al. US pharmacists effect as team members on patient care. Med Care. 2010;48:923–33.PubMedCrossRef
Metadata
Title
Clinical pharmacists and basic scientists: do patients and physicians need this collaboration?
Authors
Amir H. Zargarzadeh
Susan Jacob
Roger S. Klotz
Fadi T. Khasawneh
Publication date
01-12-2011
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2011
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-011-9562-6

Other articles of this Issue 6/2011

International Journal of Clinical Pharmacy 6/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.